Advancing TB research using digitized programmatic data

Jessica Taaffe, Júlio Croda, Harry Moultrie, D. S. Silva, Alex Rosenthal, Maha FarhatThe International Journal of Tuberculosis and Lung Disease 2021 · DOI

TL;DR

National TB programs generate vast amounts of real-world data that hold immense potential for advancing TB research. This paper highlights the opportunities and challenges in leveraging this data, advocating for standardization, improved data management, and collaboration to unlock its full research impact for public health.

What Problem Does This Paper Address?

Tuberculosis (TB) remains a significant global health challenge. While national TB care programs collect extensive data on patient care, this valuable "real-world data" is often underutilized for research. The problem is that this data is fragmented, lacks standardization, and faces significant hurdles in accessibility and interoperability, preventing researchers from fully harnessing its potential to answer critical questions about TB control, treatment outcomes, and drug resistance. The authors aim to bridge this gap by exploring how to effectively repurpose programmatic data for research.

Methods

The paper's methodology is primarily based on synthesizing insights from an expert stakeholder workshop held in October 2019. This workshop brought together academics, national TB program officers, and data managers to discuss the potential and barriers of using programmatic data for research. The authors then present a summary of the key points raised, including a proposed set of core data variables for two specific research use cases: TB treatment outcomes and molecular resistance diagnosis. They also analyze the digital data availability in Brazil and South Africa, two high TB burden countries, to illustrate current practices and identify gaps.

Datasets

The paper does not introduce new datasets or benchmarks. Instead, it discusses the characteristics and availability of existing programmatic data collected by national TB programs (NTPs) in Brazil and South Africa, as well as data aggregated by the World Health Organization (WHO). The focus is on the potential use of these existing data streams for research.

Key Insights and Ideas

  • Untapped Research Goldmine: Real-world data from national TB programs is a rich, underutilized resource with the potential to answer crucial questions about TB control, epidemiology, and clinical research.
  • Beyond Traditional Research: Programmatic data offers a unique opportunity to study TB in large, diverse populations under real-world conditions, complementing findings from clinical trials and surveys.
  • Two Key Research Avenues: The paper identifies two primary research use cases:
  • Predicting TB Treatment Outcomes: Understanding factors influencing treatment success or failure across different populations and scenarios.
  • Improving Molecular Resistance Diagnosis: Enhancing the speed and cost-effectiveness of detecting drug resistance through DNA mutation analysis.
  • Data Standardization is Crucial: A standardized data collection set across different programs is essential for enabling robust research and meaningful comparisons.
  • Data Management and Collaboration are Key: Improved data management practices and enhanced collaboration among stakeholders (researchers, program officers, data specialists) are vital for overcoming current data access and quality challenges.
  • Ethical Considerations are Paramount: Ensuring patient privacy, confidentiality, and data security is a critical concern that needs careful consideration, especially with the increasing digitization and potential for global data repositories.
  • The Urgency is Real: The need for shorter, more effective TB treatments and better control strategies for drug-resistant TB makes the urgent need for research using programmatic data clear.

Key Results

The paper does not present quantitative results in the traditional sense. Instead, it highlights:

  • Variable Availability: A comparison of data variables collected by the WHO, Brazil, and South Africa reveals that while many core variables are collected, significant gaps exist in areas like comorbid disease, treatment adherence, and adverse drug events.
  • Data Linkage Challenges: The lack of unique health identifiers in countries like Brazil and South Africa poses a significant barrier to linking different data sources (clinical, laboratory) for comprehensive analysis.
  • Infrastructure Gaps: Limited technical infrastructure, particularly in rural areas of low- and middle-income countries, hinders the widespread adoption and effective use of electronic data collection systems.
  • Progress in Digitization: Countries like Brazil and South Africa are making strides in digitizing TB data, with electronic case-based systems being favored, though challenges remain.

Limitations and Future Work

Limitations:

  • Workshop-Based Insights: The findings are largely derived from a single workshop, representing the perspectives of a specific group of stakeholders.
  • Focus on Two Countries: The detailed data availability analysis is limited to Brazil and South Africa, which may not be representative of all high TB burden countries.
  • Qualitative Nature: The paper is primarily qualitative, focusing on opportunities, challenges, and recommendations rather than presenting empirical research findings derived from the data itself.

Future Work:

  • Standardized Data Set Development: The authors advocate for the development and implementation of a standardized dataset for TB care and surveillance research.
  • Improved Data Management Tools and Training: Investing in data management tools, training programs, and technical infrastructure is crucial.
  • Unique Identifiers: Implementing unique identifiers for patients and data linkage is essential for creating comprehensive datasets.
  • Enhanced Collaboration: Fostering closer collaboration between data specialists, researchers, policymakers, and patient groups is key to maximizing data utilization.
  • Ethical Frameworks: Developing clear ethical guidelines and regulatory frameworks for data sharing is necessary.
  • Leveraging Existing Platforms: Utilizing and expanding existing platforms and tools for data sharing and analysis (e.g., TB portals) can accelerate research.

Summary updated

Abstract

The use of real-world data from national TB care programs has great potential to answer key research questions in TB control and is now opportune due to increasing digital data collection and storage. We summarize an expert stakeholder workshop conducted on this topic in October 2019, with perspectives from academics, national TB program officers, and data managers. We discuss challenges and opportunities in the use of TB programmatic data for research and describe digital data availability in two large, high TB burden countries, Brazil and South Africa. From this, we posit that with a standardized data collection set, improved data management, and greater collaboration, more TB programmatic data can be used for research with measurable public health impact.
BibTeX
@article{taaffe2021advancing,
  author = {Jessica Taaffe and Júlio Croda and Harry Moultrie and D. S. Silva and Alex Rosenthal and Maha Farhat},
  title = {{Advancing TB research using digitized programmatic data}},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2021},
  doi = {10.5588/ijtld.21.0325},
}
Figure